NCT02893878View on ClinicalTrials.gov

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

CompletedOBSERVATIONAL
Enrollment

19,334

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

November 24, 2016

Study Completion Date

November 24, 2016

Conditions
Influenza, Human
Interventions
OTHER

Vaccine safety surveillance

Extraction of routinely collected primary care data from approximately 10 volunteer English general practices by using an improved card-based ADR reporting system to estimate proportions of AEIs among seasonal influenza-vaccinated individuals.

Trial Locations (1)

GU2 7XH

GSK Investigational Site, Surrey

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
collaborator

University of Surrey

OTHER

lead

GlaxoSmithKline

INDUSTRY